PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,649,423 | -88.1% | 1,035,859 | -87.0% | 0.96% | -70.6% |
| Q1 2022 | $72,715,000 | -55.5% | 7,990,652 | 0.0% | 3.26% | -29.3% |
| Q4 2021 | $163,489,000 | -19.9% | 7,990,652 | 0.0% | 4.61% | -9.3% |
| Q3 2021 | $204,161,000 | +16.8% | 7,990,652 | +59.8% | 5.08% | +14.5% |
| Q2 2021 | $174,850,000 | +5.0% | 5,000,000 | 0.0% | 4.44% | -10.5% |
| Q1 2021 | $166,550,000 | +28.4% | 5,000,000 | 0.0% | 4.96% | +29.1% |
| Q4 2020 | $129,700,000 | +192.0% | 5,000,000 | +11.1% | 3.84% | +93.2% |
| Q3 2020 | $44,415,000 | +4058.7% | 4,500,000 | +1400.0% | 1.99% | +403.5% |
| Q2 2017 | $1,068,000 | -70.5% | 300,000 | -57.1% | 0.40% | -81.5% |
| Q1 2017 | $3,619,000 | – | 700,000 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |